C Bethan Powell

Summary

Affiliation: Kaiser Permanente
Country: USA

Publications

  1. doi Long term follow up of BRCA1 and BRCA2 mutation carriers with unsuspected neoplasia identified at risk reducing salpingo-oophorectomy
    C B Powell
    Cancer Risk Program, UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA, USA Division of Gynecologic Oncology, UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA, USA Electronic address
    Gynecol Oncol 129:364-71. 2013
  2. doi Does the diagnosis of breast or ovarian cancer trigger referral to genetic counseling?
    C Bethan Powell
    Division of Gynecologic Oncology, Kaiser Permanente Northern California, Oakland 94115, CA, USA
    Int J Gynecol Cancer 23:431-6. 2013
  3. doi Risk-reducing salpingo-oophorectomy (RRSO) in BRCA mutation carriers: experience with a consecutive series of 111 patients using a standardized surgical-pathological protocol
    C Bethan Powell
    Cancer Risk Program, Department of Pathology, UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA 94115, USA
    Int J Gynecol Cancer 21:846-51. 2011
  4. ncbi Risk-reducing salpingo-oophorectomy in BRCA mutation carriers: role of serial sectioning in the detection of occult malignancy
    C Bethan Powell
    Gynecologic Oncology Program and Cancer Risk Program, University of California San Francisco Comprehensive Cancer Center, 2340 Sutter Street, Room N424, San Francisco, CA 94143, USA
    J Clin Oncol 23:127-32. 2005
  5. doi Surveillance of survivors: follow-up after risk-reducing salpingo-oophorectomy in BRCA 1/2 mutation carriers
    Jocelyn S Chapman
    UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA 94143, USA
    Gynecol Oncol 122:339-43. 2011
  6. doi Correlation of macroscopic and microscopic pathology in risk reducing salpingo-oophorectomy: implications for intraoperative specimen evaluation
    Joseph T Rabban
    Department of Pathology, University of California San Francisco, 505 Parnassus Avenue, San Francisco, CA 94313, USA
    Gynecol Oncol 121:466-71. 2011
  7. doi Predictors of intensive care unit utilization in gynecologic oncology surgery
    Rachel Ruskin
    Division of Gynecologic Oncology, Department of Obstetrics, Gynecology, and Reproductive Sciences, Helen Diller Family Cancer Center, University of California, CA, USA
    Int J Gynecol Cancer 21:1336-42. 2011
  8. doi Perioperative outcomes comparing patient controlled epidural versus intravenous analgesia in gynecologic oncology surgery
    Lee May Chen
    Department of Obstetrics, Gynecology, and Reproductive Sciences, University of California, San Francisco, CA, USA
    Gynecol Oncol 115:357-61. 2009
  9. doi A randomized study of the effectiveness of a brief psychosocial intervention for women attending a gynecologic cancer clinic
    C Bethan Powell
    Department of Obstetrics, Division of Gynecologic Oncology, Gynecology and Reproductive Sciences, UCSF, Helen Diller Family Comprehensive Cancer Center, San Francisco, CA 94143, USA
    Gynecol Oncol 111:137-43. 2008
  10. ncbi Awareness of gynecologic surveillance in women from hereditary non-polyposis colorectal cancer families
    Kathleen Yang
    Division of Gynecologic Oncology, Department of Obstetrics, Gynecology, and Reproductive Sciences, UCSF Comprehensive Cancer Center, 1600 Divisadero St, 4th Floor, San Francisco, CA 94115, USA
    Fam Cancer 5:405-9. 2006

Collaborators

Detail Information

Publications11

  1. doi Long term follow up of BRCA1 and BRCA2 mutation carriers with unsuspected neoplasia identified at risk reducing salpingo-oophorectomy
    C B Powell
    Cancer Risk Program, UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA, USA Division of Gynecologic Oncology, UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA, USA Electronic address
    Gynecol Oncol 129:364-71. 2013
    ..We evaluated recurrence and survival outcomes of mutation carriers with neoplastic lesions identified at RRSO...
  2. doi Does the diagnosis of breast or ovarian cancer trigger referral to genetic counseling?
    C Bethan Powell
    Division of Gynecologic Oncology, Kaiser Permanente Northern California, Oakland 94115, CA, USA
    Int J Gynecol Cancer 23:431-6. 2013
    ..This study assesses adherence to genetic counseling referral guidelines within this health system...
  3. doi Risk-reducing salpingo-oophorectomy (RRSO) in BRCA mutation carriers: experience with a consecutive series of 111 patients using a standardized surgical-pathological protocol
    C Bethan Powell
    Cancer Risk Program, Department of Pathology, UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA 94115, USA
    Int J Gynecol Cancer 21:846-51. 2011
    ..We report outcomes in 111 consecutive BRCA-positive women who had RRSO using a rigorous surgical-pathological protocol from 1996 to 2008...
  4. ncbi Risk-reducing salpingo-oophorectomy in BRCA mutation carriers: role of serial sectioning in the detection of occult malignancy
    C Bethan Powell
    Gynecologic Oncology Program and Cancer Risk Program, University of California San Francisco Comprehensive Cancer Center, 2340 Sutter Street, Room N424, San Francisco, CA 94143, USA
    J Clin Oncol 23:127-32. 2005
    ..Two recent studies of BRCA mutation carriers reported occult malignancy in 2.5% of women undergoing RRSO. This study aimed to increase this detection rate using a protocol...
  5. doi Surveillance of survivors: follow-up after risk-reducing salpingo-oophorectomy in BRCA 1/2 mutation carriers
    Jocelyn S Chapman
    UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA 94143, USA
    Gynecol Oncol 122:339-43. 2011
    ..To characterize the post-operative care of BRCA1 and BRCA2 mutation carriers who undergo risk-reducing salpingo-oophorectomy (RRSO)...
  6. doi Correlation of macroscopic and microscopic pathology in risk reducing salpingo-oophorectomy: implications for intraoperative specimen evaluation
    Joseph T Rabban
    Department of Pathology, University of California San Francisco, 505 Parnassus Avenue, San Francisco, CA 94313, USA
    Gynecol Oncol 121:466-71. 2011
    ..The aim of this study was to correlate the macroscopic and microscopic pathologic findings in RRSO...
  7. doi Predictors of intensive care unit utilization in gynecologic oncology surgery
    Rachel Ruskin
    Division of Gynecologic Oncology, Department of Obstetrics, Gynecology, and Reproductive Sciences, Helen Diller Family Cancer Center, University of California, CA, USA
    Int J Gynecol Cancer 21:1336-42. 2011
    ..The objectives of the study were to examine factors predicting intensive care unit (ICU) admission after surgery for gynecologic cancer and to determine the impact of ICU admission on survival...
  8. doi Perioperative outcomes comparing patient controlled epidural versus intravenous analgesia in gynecologic oncology surgery
    Lee May Chen
    Department of Obstetrics, Gynecology, and Reproductive Sciences, University of California, San Francisco, CA, USA
    Gynecol Oncol 115:357-61. 2009
    ..Our aim was to compare perioperative patient controlled epidural analgesia (PCEA) versus patient controlled intravenous analgesia (PCA) after gynecologic oncology laparotomy...
  9. doi A randomized study of the effectiveness of a brief psychosocial intervention for women attending a gynecologic cancer clinic
    C Bethan Powell
    Department of Obstetrics, Division of Gynecologic Oncology, Gynecology and Reproductive Sciences, UCSF, Helen Diller Family Comprehensive Cancer Center, San Francisco, CA 94143, USA
    Gynecol Oncol 111:137-43. 2008
    ..While there are many psychosocial interventions for cancer patients, few are brief in nature. The aim of this study was to investigate the usefulness of a single-visit psychosocial intervention for gynecologic cancer patients...
  10. ncbi Awareness of gynecologic surveillance in women from hereditary non-polyposis colorectal cancer families
    Kathleen Yang
    Division of Gynecologic Oncology, Department of Obstetrics, Gynecology, and Reproductive Sciences, UCSF Comprehensive Cancer Center, 1600 Divisadero St, 4th Floor, San Francisco, CA 94115, USA
    Fam Cancer 5:405-9. 2006
    ..To determine knowledge of gynecologic cancer risk and screening in women with HNPCC...
  11. ncbi Aqueous extract of herba Scutellaria barbatae, a chinese herb used for ovarian cancer, induces apoptosis of ovarian cancer cell lines
    C Bethan Powell
    Department of Obstetrics, Gynecology and Reproductive Sciences, University of California San Francisco, San Francisco, CA 94143, USA
    Gynecol Oncol 91:332-40. 2003
    ....